Crossmark

Cardiac function surveillance practices and outcomes in patients with HER2-positive breast cancer treated with trastuzumab: a retrospective cohort study across a safety-net and tertiary care setting

Crossref DOI link: https://doi.org/10.1186/s40959-025-00376-9

Published Online: 2025-08-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Huang, Le

Manthena, Pratyusha

Su, Malcolm

Chandra, Alvin

Sadeghi, Navid
License Information

Text and Data Mining valid from 2025-08-21

Version of Record valid from 2025-08-21
More Information

Article History

Received: 21 June 2025

Accepted: 6 August 2025

First Online: 21 August 2025

Declarations

:

: All patients included in this study consented to their inclusion in the study. The study protocol was approved by the local Institutional Review Board.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below